Bacteriology of pediatric breast abscesses beyond the neonatal period.


Journal

The American journal of emergency medicine
ISSN: 1532-8171
Titre abrégé: Am J Emerg Med
Pays: United States
ID NLM: 8309942

Informations de publication

Date de publication:
03 2021
Historique:
received: 09 10 2020
revised: 06 11 2020
accepted: 07 11 2020
pubmed: 22 11 2020
medline: 18 3 2021
entrez: 21 11 2020
Statut: ppublish

Résumé

Limited data exist regarding the presentation and bacteriology of nonneonatal pediatric breast abscess. To determine the bacteriology and characteristic presentation of pediatric breast abscesses in a tertiary care center. Cross-sectional study of patients age 1 month to 21 years admitted to a pediatric Emergency Department (ED) between 1996 and 2018 with a breast abscess. Patients with pre-existing conditions were excluded. Records were reviewed to determine demographics, history, physical exam findings, wound culture results, imaging and ED disposition. We used descriptive statistics to describe prevalence of different bacteria. We identified 210 patients who met study criteria. Median age was 13.6 years [IQR 6.6, 17.4], and 91% (191/210) were females. Ninety-two patients (43.8%) were 'pre-treated' with antibiotics prior to ED visit, and 33/210 (16%) were febrile. Ultrasound was obtained in 85 patients (40.5%), 69 patients had a single abscess and 16 had multiple abscesses. Most patients were treated with antibiotics and 100 had a surgical intervention, of these 89 had I&D and 11 a needle aspiration. Admission rate was 45%. Culture results were available for 75 (75%). Thirty-three (44%) had a negative culture, or grew non-aureus staphylococci or other skin flora. Culture were positive for MSSA 21 (28%), MRSA 13 (17%), Proteus mirabilis 2 (2.6%), Serratia 1 (1.3%). Other organisms include Gram-negative bacilli, group A Streptococcus and enterococcus. Non-neonatal pediatric breast abscess bacteriology is no different than data published on other skin abscesses. MRSA coverage should be considered based on local prevalence in skin infections.

Sections du résumé

BACKGROUND
Limited data exist regarding the presentation and bacteriology of nonneonatal pediatric breast abscess.
OBJECTIVE
To determine the bacteriology and characteristic presentation of pediatric breast abscesses in a tertiary care center.
METHODS
Cross-sectional study of patients age 1 month to 21 years admitted to a pediatric Emergency Department (ED) between 1996 and 2018 with a breast abscess. Patients with pre-existing conditions were excluded. Records were reviewed to determine demographics, history, physical exam findings, wound culture results, imaging and ED disposition. We used descriptive statistics to describe prevalence of different bacteria.
RESULTS
We identified 210 patients who met study criteria. Median age was 13.6 years [IQR 6.6, 17.4], and 91% (191/210) were females. Ninety-two patients (43.8%) were 'pre-treated' with antibiotics prior to ED visit, and 33/210 (16%) were febrile. Ultrasound was obtained in 85 patients (40.5%), 69 patients had a single abscess and 16 had multiple abscesses. Most patients were treated with antibiotics and 100 had a surgical intervention, of these 89 had I&D and 11 a needle aspiration. Admission rate was 45%. Culture results were available for 75 (75%). Thirty-three (44%) had a negative culture, or grew non-aureus staphylococci or other skin flora. Culture were positive for MSSA 21 (28%), MRSA 13 (17%), Proteus mirabilis 2 (2.6%), Serratia 1 (1.3%). Other organisms include Gram-negative bacilli, group A Streptococcus and enterococcus.
CONCLUSIONS
Non-neonatal pediatric breast abscess bacteriology is no different than data published on other skin abscesses. MRSA coverage should be considered based on local prevalence in skin infections.

Identifiants

pubmed: 33218698
pii: S0735-6757(20)31027-5
doi: 10.1016/j.ajem.2020.11.018
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

193-196

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None of the author has a conflict of interest either financial or other.

Auteurs

Eman Ansari (E)

Boston Children's Hospital, Department of Emergency Medicine, United States of America.

Marvin B Harper (MB)

Boston Children's Hospital, Department of Emergency Medicine, United States of America; Boston Children's Hospital, Department of Pediatirc Infectious Disaeses, United States of America; Boston Children's Hospital, Clinical Informatics Fellowship Program, United States of America.

Assaf Landscahft (A)

Boston Children's Hospital, Department of Emergency Medicine, United States of America.

Rotem Kimia (R)

Boston Children's Hospital, Department of Emergency Medicine, United States of America.

Alex Lynn (A)

Boston Children's Hospital, Department of Emergency Medicine, United States of America.

Al Ozonoff (A)

Boston Children's Hospital, Department of Pediatirc Infectious Disaeses, United States of America.

Amir A Kimia (AA)

Boston Children's Hospital, Department of Emergency Medicine, United States of America; Boston Children's Hospital, Clinical Informatics Fellowship Program, United States of America. Electronic address: amir.kimia@childrens.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH